Composed of an assortment of twenty-one libraries including FDA-approved drug library, natural product library, and anti-cancer compound library, among others, the bioactive screening libraries at BOC Sciences are ready-to-use chemical libraries for drug discovery, lab drug screening, drug target identification, and other pharmaceutical-related applications. These libraries consist of a unique and diverse collection of thousands of compounds with validated biological and pharmacological activities, in which each library corresponds to a particular category of materials that can be harnessed for high screening and high content screening.For quality assurance purposes, a full characterization report or a Certificate of Analysis (COA) is prepared and NMR spectroscopy and HPLC chromatography performed to validate the purity level and chemical structure of every compound supplied by BOC Sciences.
|BOCSL-21||Ion Channel Ligand|
|BOCSL-19||Stem Cell Signaling Compound|
|BOCSL-14||Target selective Inhibitor|
|BOCSL-13||Tyrosine Kinase Inhibitor|
|BOCSL-7||Pfizer Licensed Compound|
|BOCSL-6||Cambridge cancer Compound|